​

CNS Pharmaceuticals Ownership | Who Owns CNS Pharmaceuticals?

OverviewForecastFinancialsChart

CNS Pharmaceuticals Ownership Summary

CNS Pharmaceuticals is owned by 4.10% institutional investors, 0.95% insiders, and 94.95% retail investors. Geode capital management is the largest institutional shareholder, holding 0% of CNSP shares. Fidelity Extended Market Index is the top mutual fund, with 0.57% of its assets in CNS Pharmaceuticals shares.

CNSP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCNS Pharmaceuticals4.10%0.95%94.95%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Geode capital management---
Mai capital management---
Citigroup---
Caitong asset management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Geode capital management---
Mai capital management---
Citigroup---
Caitong asset management---

Top Buyers

HolderShares% AssetsChange
Citigroup---1.00
Caitong asset management---1.00
Mai capital management---3.00
Geode capital management---23.19K

Top Sellers

HolderShares% AssetsChange
Geode capital management---23.19K
Mai capital management---3.00
Citigroup---1.00
Caitong asset management---1.00

Sold Out

HolderChange
Citigroup-1.00
Caitong asset management-1.00
Mai capital management-3.00
Geode capital management-23.19K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202611-280,43492.61%490.46%6-2-
Mar 31, 20261122.22%145,59617.19%212.74%650.00%--100.00%
Dec 31, 2025912.50%124,237404.70%28144.44%4-1-75.00%
Sep 30, 20258-20.00%24,616-95.20%43.30%4-50.00%4-
Jun 30, 20251042.86%512,7451163.11%11520.83%8166.67%--100.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index8.32K0.57%1.59K
Vanguard Institutional Extnd Mkt Idx Tr6.99K0.48%-
NT Ext Equity Mkt Index Fund - NL1.33K0.09%1.33K
NT Ext Equity Mkt Idx Fd - DC - NL - T2967.000.07%967.00
JHVIT Total Stock Market Index I2.38K0.04%-
Fidelity Series Total Market Index555.000.04%-
Spartan Total Market Index Pool G345.000.02%-
Spartan Total Market Index Pool A1345.000.02%-
Spartan Extended Market Index Pool E145.000.01%42.00
Spartan Extended Market Index Pool F81.000.01%-

Recent Insider Transactions

DateNameRoleActivityValue
May 18, 2026Fisher Michal-Buy$10.00K
May 18, 2026Charles Faith L.-Buy$34.00K
Feb 01, 2024Gumulka Jerzy-Buy$10.00K
Feb 01, 2024Evans Carl Anthony-Buy$10.00K
Feb 01, 2024Downs Christopher Chief Financial OfficerBuy$20.00K

Insider Transactions Trends

DateBuySell
2026 Q21-
2026 Q1--
2025 Q4--
2024 Q3--
2024 Q2--

CNSP Ownership FAQ

Who Owns CNS Pharmaceuticals?

CNS Pharmaceuticals shareholders are primarily institutional investors at 4.10%, followed by 0.95% insiders and 94.95% retail investors. The average institutional ownership in CNS Pharmaceuticals's industry, Biotech Stocks , is 379.61%, which CNS Pharmaceuticals falls below.

Who owns the most shares of CNS Pharmaceuticals?

CNS Pharmaceuticals’s largest shareholders are Geode capital management (0 shares, 0%), Mai capital management (0 shares, 0%), and Citigroup (0 shares, 0%). Together, they hold 0% of CNS Pharmaceuticals’s total shares outstanding.

Does Blackrock own CNS Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of CNS Pharmaceuticals.

Who is CNS Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Geode capital management is CNS Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 CNS Pharmaceuticals shares, valued at 0$.

Who is the top mutual fund holder of CNS Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of CNS Pharmaceuticals shares, with 0.57% of its total shares outstanding invested in 8.32K CNS Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools